Hans Glise MD, PhD has a professorship in surgery, vast experience of clinical research both from the clinical side and as Head of Clinical research in several Therapy Areas in Astra Zeneca, Novo Nordisk and UCB. Dr Glise also was the drivning force behind the creation of SCUR, a clinical research group of 30 clinics in medicine and Surgery in Sweden, Norway and Finland.

Ahsan is a health-tech entrepreneur and investor specialising in digital health and immunotherapy. In addition to his role at ITH, Ahsan is co-Founder/Chairman at Accelerated Innovation and Managing Director at TLA, and has been an investor and Board member at several digital health companies such as Geras Solutions, KRY, HerCare, ImagineCare, and ABC Labs.

Ola is a Senior Consultant in Clinical Immunology at Karolinska University Hospital and co-founder of several biotech companies based on his inventions. Previously, Ola was a Professor of Cellular Immunotherapy and Head of Translational Immunology at the Karolinska Institutet.

Martin holds a double B.Sc degree from Stockholm University and University of Greenwich, UK. Martin has been working with TLA since 2015.

Extensive experience of managing biotechnology and pharmaceutical companies. Previously, President, CEO, and Chairman of the Board in Companies including Farmos Group, Ferring and Nordic Group.

Experience in strategy consulting and finance. Partner at Implement Consulting Group. Previosly, Vice President at CapGemini, and Auditor at E&Y.